WO2002065131A1 - Method of detecting bacterium belonging to the genus vibrio, detection reagent and antibody to be used therein - Google Patents

Method of detecting bacterium belonging to the genus vibrio, detection reagent and antibody to be used therein Download PDF

Info

Publication number
WO2002065131A1
WO2002065131A1 PCT/JP2002/001064 JP0201064W WO02065131A1 WO 2002065131 A1 WO2002065131 A1 WO 2002065131A1 JP 0201064 W JP0201064 W JP 0201064W WO 02065131 A1 WO02065131 A1 WO 02065131A1
Authority
WO
WIPO (PCT)
Prior art keywords
vibrio
antibody
ldh
sample
detecting
Prior art date
Application number
PCT/JP2002/001064
Other languages
French (fr)
Japanese (ja)
Inventor
Hiroki Tatsumi
Satoshi Fukuda
Sumio Shinoda
Shin-Ichi Miyoshi
Yoko Maehara
Original Assignee
Kikkoman Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kikkoman Corporation filed Critical Kikkoman Corporation
Priority to JP2002564598A priority Critical patent/JPWO2002065131A1/en
Publication of WO2002065131A1 publication Critical patent/WO2002065131A1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria

Definitions

  • the present invention relates to a method for detecting a genus Vibrio, a reagent for detecting a bacterium of the genus Vibrio, and an antibody used therefor.
  • Vibrio parahaemolyt icus a member of the genus Vibrio, is the causative agent of most seafood poisoning in summer in Japan.
  • secondary-contaminated cooked foods and drinking water can be food-causing foods. Testing for Vibrio parahaemolyticus in foods and drinks is essential to assess safety.
  • samples of fish and shellfish, food and drink, etc. are cultured in saline polymyxin broth (manufactured by Nissui) at 37 ° C for 18 hours, and then spread on TCBS agar medium (manufactured by Nissui), and then incubated at 37 ° C, 18 ° C. Incubate for hours.
  • Vibrio parahaemolyticus forms non-sucrose-degradable green-blue colonies of about 2 mm in diameter on TCBS agar medium.
  • non-saccharide-degrading Vibrio bacteria often form similar colonies of the same color as Vibrio parahaemolyticus, so a primary confirmation test and possibly a secondary confirmation test were performed to distinguish them from each other. Required.
  • LDH Lecithin Dependent Hemolysin
  • the hybridization method and the PCR method using the LDH gene as a detection marker have the following disadvantages.
  • An object of the present invention is to provide a method for quickly and simply and accurately detecting a Vibrio bacterium and a reagent for detection capable of solving the problems of the prior art.
  • the present inventors have studied the above problems and found that by detecting LDH produced by Vibrio sp. In a sample using an antibody capable of reacting with LDH derived from Vibrio sp. The present inventors have found that genus bacteria (particularly, Vibrio parahaemolyticus or Vibrio alginolyticus) can be detected, and completed the present invention. Summary of the Invention
  • the present invention provides the following methods and products.
  • a method for detecting a bacterium of the genus Vibrio in a sample comprising the step of:
  • Vibrio bacterium is Vibrio parahaemolyt icus or Vibrio alginolyticas.
  • a reagent for detecting a Vibrio bacterium which comprises an antibody capable of reacting with LDH derived from a Vibrio bacterium. 6. The detection reagent according to the above item 5, wherein the bacterium of the genus Vibrio is Vibrio parahaemolyticus or Vibrio alginolyticus.
  • the method for detecting a bacterium of the genus Vibrio of the present invention is characterized by including the following first and second steps.
  • an antibody capable of reacting with LDH derived from bacteria of the genus Vibrio (hereinafter referred to as “anti-LDH antibody”) is brought into contact with a sample to generate an antigen-antibody reaction. If the sample contains Vibrio spp. That produces L dishes, the anti-LDH antibody and the LDH produced by the bacterium cause an antigen-antibody reaction.
  • the reaction product obtained in the first step is detected.
  • detection of Vibrio spp. Bacteria (particularly Vibrio parahaemolyticus or Vibrio alginolyticus) in the sample becomes possible.
  • the method of the antigen-antibody reaction (first step) and the detection of the reaction product (second step) are not particularly limited, and a known method utilizing an immune reaction can be used.
  • the method usable in the present invention include enzyme immunoassay (EIA), radioimmunoassay (RIA), fluorescence immunoassay (FIA), electrochemical immunoassay, immunoagglutination, immunochromatography. And the like.
  • the sample prior to the first step, is preferably cultured in a medium to increase the number of bacteria of the genus Vibrio. This makes it possible to improve the detection sensitivity of Vibrio spp. Bacteria.
  • the medium is not particularly limited as long as it is capable of growing Vibrio spp., But it is particularly preferable to use a selective medium for Vibrio spp. By using a selective medium, it is possible to enrich Vibrio spp. In a sample. As shown in the Examples, when the detection method of the present invention is used, enteritis virus present in a sample can be obtained.
  • Vibrio parahaemolyt icus or Vibrio alginolyticas (Vibrio alginolyt icus) can be detected quickly, conveniently and accurately. Further, the detection method of the present invention can also be used as a method for detecting other Vibrio bacteria that can react with an anti-LDH antibody.
  • the sample is not particularly limited, but includes, for example, raw and processed fish and shellfish, food and drink, seawater, river water, dishes and cooking utensils, and the like.
  • the sample may be filtered using a membrane filter or the like, and a sample obtained by capturing microorganisms on the filter may be used as the sample.
  • Vibrio spp. Attached to food or cooking utensils, wipe the food or cooking utensils with a cotton swab impregnated with saline solution or buffer solution, and remove the resulting adhering substances appropriately.
  • a sample suspended in a liquid or medium may be used as the sample.
  • microbes may be extracted from food using a stomacher or the like, and the resulting extract may be used as a sample.
  • the “anti-LDH antibody” may be any antibody as long as it can react with LDH derived from Vibrio sp., For example, an antibody obtained by immunizing an animal with LDH derived from Vibrio sp. As an antigen is used. it can. As the anti-LDH antibody, any of a polyclonal antibody and a monoclonal antibody can be used. Furthermore, a recombinant anti-LDH antibody prepared using the anti-LDH antibody gene can also be used. Polyclonal antibodies can be obtained from the sera of sensitized animals. The sensitization can be carried out by injecting the LDH protein as an antigen into mammals, preferably, egrets, goats and cattle. Normally, the first injection is followed by a booster injection to maximize the immune response, and then sera from the sensitized animals are collected. Monoclonal antibodies can be obtained by producing hybridomas capable of producing anti-LDH antibodies by cell fusion.
  • LDH protein can be purified from cultures of Vibrio parahaemolyticus.
  • the LDH gene of Vibrio parahaemolyticus is already known (Taniguclii et al., Microb. Pathog., 1, 425, (1986)).
  • the LDH protein is produced by producing the gene in an appropriate host cell-vector system, and the LDH protein can be isolated by purifying the LDH protein. By sensitizing appropriate animals using LDH protein as an antigen, LDH antibodies are obtained.
  • a recombinant antibody single chain Fv or Fab
  • a microorganism such as Escherichia coli as a host.
  • the anti-LDH antibody may be chemically modified depending on the method of the antigen-antibody reaction (first step) and the detection of the reaction product (second step).
  • first step the antigen-antibody reaction
  • second step the detection of the reaction product
  • the anti-LDH antibody is biotinylated by a known method.
  • Fish, seafood and food and drink can be directly used as samples and inoculated directly into the culture medium.
  • An extract obtained by extracting microorganisms from food or drink or the like may be used as a sample.
  • microorganisms adhering to food or cooking utensils may be wiped off with a cotton swab, and then the microorganisms may be transferred to a culture medium and cultured.
  • the filter can be placed on a solid medium or the captured substance can be suspended in the liquid medium.
  • the medium is not particularly limited as long as it can grow Vibrio spp., But by using a selective medium for Vibrio spp., The Vibrio spp. In the sample can be concentrated.
  • Selection media include TCBS agar medium, Vibrio agar medium, salt polymyxin broth, alkaline peptone water (Nissui, etc.), 1.5% salt-added Heart Infusion Broth (HIB) Abbreviation, manufactured by Diico).
  • a selective medium the sample may be applied directly to the agar medium, or the sample may be cultured in a liquid medium. Further, after liquid culture, it may be applied to an agar medium. When overnight culture medium is used, the quantitative test can be performed by the most probable method.
  • the cultivation temperature of the genus Vibrio is 15 ° C to 45 ° C, preferably about 30 ° C to 40 ° C.
  • the culture may be aerated or closed. If a liquid medium is used, the culture may be shaken as necessary.
  • an anti-LDH antibody is brought into contact with the culture to generate an antigen-antibody reaction (first step), and then the reaction product is detected (second step).
  • first step an anti-LDH antibody is brought into contact with the culture to generate an antigen-antibody reaction
  • second step the reaction product is detected
  • LDH may be detected from any of the whole culture, the culture supernatant, the cells, and the disrupted cells.
  • the method of disrupting the cells may be any method as long as it does not change the antibody recognition structure of LDH, and examples thereof include ultrasonic treatment, treatment with a lytic enzyme or a lytic agent, and French press.
  • the culture may be once cultured on a selective medium of Vibrio parahaemolyticus such as TCBS agar medium, and LDH may be detected directly from the colony suspected of Vibrio parahaemolyticus or after culture in the medium.
  • the antigen-antibody reaction and the detection of the reaction product can be performed using enzyme immunoassay (EIA), radioimmunoassay (RIA), electrochemical immunoassay, immunoagglutination, immunochromatography, and the like.
  • EIA enzyme immunoassay
  • RIA radioimmunoassay
  • electrochemical immunoassay immunoagglutination
  • immunochromatography and the like.
  • an enzyme immunoassay there are a sandwich method and a competitive method.
  • sandwich method first, an anti-LDH antibody is bound to a carrier, then brought into contact with a sample, and then contacted with a labeled anti-LDH antibody (for example, an antibody-enzyme complex, biotinylated antibody). Finally, if necessary, a second label (for example, a biotinylated luciferase ostreptoavidin complex) is contacted. LDH can be detected by measuring the label or the second label by an enzyme reaction.
  • a labeled anti-LDH antibody for example, an antibody-enzyme complex, biotinylated antibody
  • a second label for example, a biotinylated luciferase ostreptoavidin complex
  • an anti-LDH antibody is first bound to a carrier, and then a sample and a labeled LDH (eg, an LDH-enzyme complex, a biotinylated LDH) are added, and if necessary, a second labeled substance (eg, LDH can be detected by contacting the product with a biotinylated luciferase-sestrebutavidin complex) and measuring the label or the second label by an enzyme reaction.
  • LDH labeled LDH
  • a second labeled substance eg, LDH can be detected by contacting the product with a biotinylated luciferase-sestrebutavidin complex
  • an anti-LDH antibody is sensitized to latex particles, gold colloid, or the like, and then the sample is brought into contact with the sample. Thereafter, LDH force can be detected by detecting agglutination, which is a reaction product.
  • Vibrio spp. Especially Vibrio parahaemolyticus or Bib
  • Rio alginolyticus V. alginolyticus
  • Vibrio parahaemolyticus and Vibrio alginolyticus were contained in the sample.
  • V. alginolyt icus If only one species (V. alginolyt icus) needs to be detected, cultivation is carried out using a selective medium in order to separate the two prior to performing the antigen-specific antibody reaction.
  • a selective medium for Vibrio spp., Vibrio parahaemolyticus, which is non-degradable by sucrose, forms a green-blue colony, whereas Vibrio arginolyticus (V alginolyt icus) is known to form yellow settlements.
  • the detection reagent of the present invention is characterized by containing an anti-LDH antibody.
  • the reagent is used in the method for detecting a bacterium of the genus Vibrio of the present invention.
  • the reagent contains, in addition to the anti-LDH antibody, other components necessary for the detection of Vibrio spp., Or components (preservatives, pH adjusters, antioxidants, etc.) that allow each reaction step to proceed stably. May be included.
  • the shape of the detection reagent of the present invention may be a solution or a solid.
  • the reagent in the form of a solution is, for example, a solution in which an anti-LDH antibody is dissolved in an appropriate solvent.
  • the solid-state reagent is, for example, one in which an anti-LDH antibody is immobilized on a solid carrier such as a well or a latex particle for immunoassay.
  • E. coli C600pHL591 strain in which the LDH gene of Vibrio parahaemolyticus has been cloned (Taniguchi et al., Microb. Pat og., 1, 425 (1986)) was used in ⁇ ⁇ 5 mL.
  • the cells were cultured at 37 ° C for 8 hours with shaking, inoculated into 500 mL of HIB, and then cultured at 37 ° C for 16 hours with shaking.
  • the cells were centrifuged at 7000Xg for 40 minutes to collect the cells. Periplasmic fractions were obtained from these cells by the osmotic shock method according to the method of Neu and Neppel (J. Biol. Chem., 240, 3685 (1965)).
  • ammonium sulfate was added so as to obtain a 65% saturation (420 g / L), left at 4 ° C for a while, and then centrifuged at 7000Xg for 40 minutes to collect a precipitate.
  • the resulting precipitate was dissolved in 3 mL of 0.15 M NaCl / 20 mM histidine monohydrochloride (Histidine_HCl) buffer (pH 5.5), dialyzed against the same buffer overnight, and centrifuged to remove insolubles.
  • Histidine_HCl histidine monohydrochloride
  • the supernatant was added to an anion exchanger Mono Q HR 5/5 column equilibrated with a 0.15 M NaCl / 20 mM histidine-HCl (Histidine-HC1) buffer solution (pH 5.5), and high-performance liquid chromatography was performed. That is, after the unadsorbed protein was washed with the same buffer, the protein was eluted with the same buffer containing 0.9 M NaCl, and a fraction having poma erythrocyte hemolytic activity (ie, LDH activity) was collected.
  • Histidine-HC1 histidine-HC1 buffer solution
  • the erythrocyte hemolytic activity was determined by reacting the sample with 0.5% erythrocytes in the presence of 50 ig / mL lecithin at 37 ° C for 2 hours to determine the presence or absence of hemolysis. As a control, a reaction was performed in the absence of lecithin, and the difference was determined.
  • the anti-LDH antibody was purified from the anti-LDH antiserum using a MabTrap GII kit (Amersham Pharmacia Biotech) and desalted using a PD-10 column (Amersham Pharmacia Biotech). The protein concentration was measured with BCA Protein Atssay reagent (Pierce). From 1.5 mL of antiserum, 3.5 mL (1.1 mg / mL) of anti-LDH antibody (polyclonal antibody) was purified.
  • TBS Tris buffered saline
  • PROC Ace Dainippon Pharmaceutical Co., Ltd.
  • biotinylated anti-LDH antibody prepared with (2) diluted 3,000-fold with 10% Block Ace and add 37 ° C. C for 1 hour, and the reaction between LDH bound to the solid phase antibody and the biotinylated anti-LDH antibody was performed.
  • the biotinylated reagent kit (trade name: InteliteAB, manufactured by Kikkoman Co., Ltd.) containing a biotinylated luciferase zestrebutavidin complex solution (complex ) Add IOO L and set at 37 ° C 30 Then, the mixture was allowed to react with the biotinylated anti-LDH antibody and the complex. After washing 3 times with TBS containing Tween 20 of 0.1, cut off the cell of C8 MAXI BREAKAPART NUNC-1 (C8 MAXI BREAKAPART NUNC-1 picture NO MODULE, Nunc) and emit light.
  • C8 MAXI BREAKAPART NUNC-1 C8 MAXI BREAKAPART NUNC-1 picture NO MODULE, Nunc
  • Bacteria by the latex agglutination method can be performed by the following method.
  • the antibody is sensitized to the latex particles.
  • Polybead polystyrene microspheres (diameter ⁇ ⁇ , manufactured by Polysciences, Inc.) are used as latex particles.
  • Latex particles 2.5 Put 0.5 mL of suspension into a microphone mouth tube, add 1 mL of borate buffer (0.1 M Borate, pH 8.5), and after turbidity, centrifuge for latex Collect the particles. The procedure of resuspending this in 1 mL of borate buffer and centrifuging is repeated twice, and then resuspended in 1 mL of borate buffer.
  • the anti-LDH antibody obtained in Example 1 (2) is added to a concentration of 25 g / mL, and left at room temperature for 16 hours under shaking at 20 rpm.
  • the latex particles sensitized with the anti-LDH antibody obtained above are one of the detection reagents of the present invention.
  • Example 1 (3) The sample prepared in Example 1 (3) and the latex particles sensitized with the anti-LDH antibody described above were diluted with a diluent (phosphate buffered saline containing 0.5% bovine serum albumin and 0.1% NaN 3). ) Dilute each 10-fold with. Add 252 L of each diluted sample to each well of a V-shaped microplate (Course Yuichisha). Next, 25 diluted dilute latex particles are added dropwise thereto, and the mixture is shaken and stirred with a mixer for a microplate, and then left at room temperature for 18 hours to observe aggregation of each well.
  • a diluent phosphate buffered saline containing 0.5% bovine serum albumin and 0.1% NaN 3
  • V. alginolyticus Culture supernatants of Vibrio parahaemolyticus and Vibrio alginolyticus (V. alginolyticus) cause latex aggregation, but other culture supernatants do not. That is, by using the Latec particles sensitized with the anti-LDH antibody, Vibrio parahaemolyticus and V. alginolyticus can be efficiently detected.
  • the enzyme immunoassay and the latex agglutination method described above can detect only Vibrio parahaemolyticus and V. alginolyticus producing LDH.
  • Vibrio parahaemolyticus is a bacterium that causes food poisoning and requires food hygiene control, but V. alginolyticus (V. alginolyt icus) does not cause food poisoning, so it is desirable to distinguish between the two.
  • Vibrio parahaemolyticus which is non-sucrose-degrading on TCBS agar medium (manufactured by Nissui), which is a selective medium for Vibrio bacteria, forms a green-blue colony.
  • Vibrio spp.grown on TCBS agar was suspended in mL of HIB liquid medium containing 1.5% sodium chloride, incubated at 37 ° C for 6 hours, and then 1 mL of the culture was transferred to a microphone mouth tube.
  • the culture supernatant was prepared by centrifugation.
  • Vibrio parahaemolyticus and V. alginolyticus were positive, and all the other strains were negative. .
  • the selective culture of Vibrio parahaemolyticus and Vibrio alginolyticus can also be performed prior to the latex aggregation method described in Example 2.
  • V. alginolyt icus respectively. Strain name EIA * TCBS ⁇ V. parahaemolyticus AQ3354 positive green-blue V. parahaemolyticus RIMD2210518 positive green-blue V. parahaemolyticus 93-200 positive green-blue V. parahaemolyticus 93- 347 positive green-blue tl paste V. ⁇ ⁇ lCUS V i Q V. parahaemolyticus OP-377 positive green-blue enteritis vibrio (V. parahaemolyticus) 93-100 positive green-blue enteritis vibrio (V. parahaemolyticus) 93- 346 positive green blue Vibrio alginolyticus (V. alginolyticus)
  • Vibrio hollisae (V. hollisae) CDC9041-81 negative green-blue Vibrio, hollisae (V. hollisae) CDC0075-80 negative green-blue Vibrio furnissii (V. furnissii) Q17 negative yellow picture 4119 negative yellow
  • Vibrio fluvialis V. fluvialis
  • Vibrio spectacularus V. splendidus
  • the present invention by detecting an LDH produced by a Vibrio bacterium in a sample using an antibody capable of reacting with LDH derived from a Vibrio bacterium, a Vibrio bacterium (particularly, Vibrio parahaemolyticus or Vibrio spp. alginolyt icus) was detected.
  • the present invention provides a reagent for detecting Vibrio bacteria, which comprises an antibody capable of reacting with LDH derived from Vibrio bacteria.
  • Vibrio parahaemolyticus and Vibrio alginolyticus can be identified within a single test day from a colony on a selective agar medium. It is. Also, in the latex agglutination method described in Examples 2 and 3, it is possible to identify from the colonies on the selective agar medium the next day by one type of test. It has been shown that the use of the method of the present invention makes the operation simpler than the conventional method and shortens the inspection time by one to two days.
  • the present invention is useful in fields such as food hygiene, medical treatment, and scientific research on bacteria of the genus Vibrio.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

A method of detecting bacterium belonging to the genus Vibrio) characterized by involving: (1) a first step of bringing an antibody, which can react with a lecithin-dependent hemolysin originating in the bacterium belonging to the genus Vibrio , into contact with a sample to induce an antigen-antibody reaction; and (2) a second step of detecting the reaction product obtained in the first step; a reagent for detecting bacterium belonging to the genus Vibrio characterized by containing an antibody which can react with a lecithin-dependent hemolysin originating in the bacterium belonging to the genus Vibrio; and an antibody which can react with a lecithin-dependent hemolysin originating in a bacterium belonging to the genus Vibrio, usable in the above detection method and detection reagent.

Description

明 細 書 ビブリオ属細菌の検出法および検出用試薬ならびにこれらに使用する抗体 技術分野  Description Method for detecting Vibrio spp., Reagents for detection, and antibodies used therefor
本発明は、 ビブリオ属細菌の検出法、 およびビブリオ属細菌の検出用試薬な らびにこれらに使用する抗体に関する。 背景技術  The present invention relates to a method for detecting a genus Vibrio, a reagent for detecting a bacterium of the genus Vibrio, and an antibody used therefor. Background art
ビブリオ属細菌の一種である腸炎ビブリオ (Vibrio parahaemolyt icus) は、 日本において夏期の魚介類による食中毒の大半の原因菌である。 腸炎ビブリオ が感染した生の魚介類はもとより、 2次汚染された調理食品および飲料水も、 食中毒の原因食品となる。 安全性を評価するため、 飲食品中の腸炎ビブリオの 検査は必要不可欠である。  Vibrio parahaemolyt icus, a member of the genus Vibrio, is the causative agent of most seafood poisoning in summer in Japan. In addition to raw seafood infected with Vibrio parahaemolyticus, secondary-contaminated cooked foods and drinking water can be food-causing foods. Testing for Vibrio parahaemolyticus in foods and drinks is essential to assess safety.
腸炎ビブリオの検出法としては、 以下の方法が知られていた (食品衛生検査 指針微生物編 (社団法人日本食品衛生協会、 1990年) による) 。  The following methods were known as methods for detecting Vibrio parahaemolyticus (according to Food Sanitation Inspection Guideline Microorganisms (Japan Food Hygiene Association, 1990)).
まず、 魚介類や飲食品等の試料を、 食塩ポリミキシンブイヨン (日水社製) で 37°C、 18時間培養後、 TCBS寒天培地 (日水社製など) に塗抹し、 37°C、 18 時間培養する。 腸炎ビブリォは TCBS寒天培地上で直径 2 mm内外の白糖非分解 性の緑青色の集落を作る。 しかし、 白糖非分解のビブリオ属の細菌が、 腸炎ビ ブリオと同色の類似した集落を形成する場合が多々あるので、 それらと識別を するため 1次確認テストおよび場合によっては 2次確認テス卜が必要となる。  First, samples of fish and shellfish, food and drink, etc. are cultured in saline polymyxin broth (manufactured by Nissui) at 37 ° C for 18 hours, and then spread on TCBS agar medium (manufactured by Nissui), and then incubated at 37 ° C, 18 ° C. Incubate for hours. Vibrio parahaemolyticus forms non-sucrose-degradable green-blue colonies of about 2 mm in diameter on TCBS agar medium. However, non-saccharide-degrading Vibrio bacteria often form similar colonies of the same color as Vibrio parahaemolyticus, so a primary confirmation test and possibly a secondary confirmation test were performed to distinguish them from each other. Required.
1次確認テストでは、 以下の 6種類の試験を用いて、 括弧内に記載の性質を 調べる  In the primary confirmation test, the properties described in parentheses are examined using the following six tests
( 1 ) l% NaCl添加普通寒天 (ォキシダ一ゼ)  (1) l% NaCl added ordinary agar (Oxidase)
( 2 ) 1% NaCl添加 TSI寒天 (硫化水素、 ガス、 ブドウ糖発酵)  (2) 1% NaCl added TSI agar (hydrogen sulfide, gas, glucose fermentation)
( 3 ) 1% NaCl添加 SIM培地 (インドール、 インドールピルビン酸、 運動 性) (4) 1% NaCl添加リシン培地 (リシン ·デカルポキシラーゼ) (3) SIM medium supplemented with 1% NaCl (indole, indole pyruvate, motility) (4) 1% NaCl added lysine medium (lysine decarboxylase)
(5) 1¾ NaCl添加 VP半流動培地 (Voges- Proskauer)  (5) 1¾ NaCl added VP semi-fluid medium (Voges- Proskauer)
(6) 0, 3, 8, 10% NaCl添加ブイヨン (発育)  (6) Broth with 0, 3, 8, and 10% NaCl (Development)
以上のテス卜で確認できない場合には、 さらに次の 4種の試験を用いる 2次 確認テストを行い、 同定する。  If the above test does not confirm, a secondary confirmation test using the following four types of tests is further performed to identify.
(7) 〇_ニトロフエニル ]3— D—ガラクトピラノシド (0_nitrophenyl β - D - galactopyranoside, 0NPG)  (7) 〇_nitrophenyl] 3-D-galactopyranoside (0_nitrophenyl β-D-galactopyranoside, 0NPG)
(8) 1% NaCl添加オル二チン培地  (8) Orditin medium supplemented with 1% NaCl
(9) 1% NaCl添加アルギニン培地  (9) 1% NaCl added arginine medium
(10) 1% NaCl添加糖分解テスト用培地 (ァラビノース、 マルトース、 ィ ノシット、 キシロース、 サリシン、 マンニット、 マンノース、 白糖)  (10) 1% NaCl-containing medium for glycolysis test (arabinose, maltose, inosit, xylose, salicin, mannitol, mannose, sucrose)
以上の腸炎ビブリオ検出の確認テストは、 多数の試験からなるため、 手間、 培地費用および時間がかかる。 このため、 これらの確認テス卜に代わる迅速、 簡便、 正確なテストが望まれていた。  The above confirmation test for detection of Vibrio parahaemolyticus consists of a large number of tests, which requires labor, medium costs and time. Therefore, a quick, simple, and accurate test alternative to these confirmation tests has been desired.
レシチン依存性へモリシン (Lecithin Dependent Hemolysin (LDH) ) (別 名 Thermolabile Hemolysin) は、 易熱性の溶血毒で、 ホスホリパーゼ A 2 Lecithin Dependent Hemolysin (LDH) (also known as Thermolabile Hemolysin) is a thermolabile hemotoxin with phospholipase A 2
(phospholipase A2) 活性およびリソホスホリパーゼ (lysophosp o-lipase) 活性を持つ蛋白質である (Shinoda et al. , J. Gen. Microbiol., 137, 2705 (1991)) 。 水口と谷口は、 コロニーハイブリダィゼ一シヨン及びサザンブロッ トハイブリダィゼーシヨンにより、 調べた 121株全ての腸炎ビブリオに LDH遺 伝子が存在し、 腸炎ビブリォ以外のビブリォ属細菌 22株には LDH遺伝子が存 在しないことを報告している (三輪谷俊夫、 大橋誠監修、 腸炎ビブリオ第 III 集、 131ページ、 近代出版) 。 It is a protein having (phospholipase A2) activity and lysophospho-lipase activity (Shinoda et al., J. Gen. Microbiol., 137, 2705 (1991)). Mizuguchi and Taniguchi found that the LDH gene was present in all 121 strains of Vibrio parahaemolyticus by colony hybridization and Southern blot hybridization and that 22 strains of Vibrio spp. Other than Vibrio parahaemolyticus were present. It has been reported that the LDH gene does not exist (Toshio Miwaya, Makoto Ohashi, Vibrio parahaemolyticus III, p. 131, Modern Press).
近年、 ベジ等 (Bej, et. al. ) (J. Microbiological Methods, 36, 215 (1999)) およびマッカーシー等 (McCarthy, et. al. ) (Lett. Appl. Microbiol. 28, 66 (1999)) はそれぞれ、 PCR法、 DNAハイブリダィゼ一シヨン法に より、 腸炎ビブリオから LDH遺伝子が検出され、 非腸炎ビブリオから LDH遺伝 子が検出されないことを示し、 LDH遺伝子が腸炎ビブリオの検出マ一力一とし て有用なことを示した。 Recently, Bej et al. (J. Microbiological Methods, 36, 215 (1999)) and McCarthy et al. (Lett. Appl. Microbiol. 28, 66 (1999)) Indicates that the LDH gene was detected from Vibrio parahaemolyticus and not from Vibrio parahaemolyticus by the PCR method and DNA hybridization method, respectively. And useful.
しかしながら、 LDH遺伝子を検出マーカ一とするハイブリダィゼ一ション法 や PCR法には、 以下のような欠点が存在する。  However, the hybridization method and the PCR method using the LDH gene as a detection marker have the following disadvantages.
•微生物の DNAを扱うため操作が煩雑で時間を要する。  • The operation is complicated and time consuming to handle the DNA of microorganisms.
·特別の機器が必要  · Special equipment required
•類似の DNA配列を持つ非腸炎ビブリオと反応する可能性がある。  • May react with non-enteritis vibrio with similar DNA sequences.
本発明は、 従来技術の課題を解決できる、 迅速、 簡便かつ正確なビブリオ属 細菌の検出法および検出用試薬の提供を目的とする。  An object of the present invention is to provide a method for quickly and simply and accurately detecting a Vibrio bacterium and a reagent for detection capable of solving the problems of the prior art.
本発明者らは上記課題について検討した結果、 ビブリォ属細菌由来の LDHと 反応し得る抗体を用いて試料中のビブリオ属細菌が生産する LDHを検出するこ とにより、 迅速、 簡便かつ正確にビブリオ属細菌 (特に、 腸炎ビブリオまたは Vibrio alginolyt icus) が検出できることを見出し、 本発明を完成した。 発明の要旨  The present inventors have studied the above problems and found that by detecting LDH produced by Vibrio sp. In a sample using an antibody capable of reacting with LDH derived from Vibrio sp. The present inventors have found that genus bacteria (particularly, Vibrio parahaemolyticus or Vibrio alginolyticus) can be detected, and completed the present invention. Summary of the Invention
即ち、 本発明は、 下記の方法および物を提供するものである。  That is, the present invention provides the following methods and products.
1 . ( 1 ) ビブリオ属細菌由来の LDHと反応し得る抗体を、 試料と接触させて 抗原抗体反応を生じさせる第 1工程、 及び  1. (1) a first step of bringing an antibody capable of reacting with LDH derived from a bacterium of the genus Vibrio into contact with a sample to generate an antigen-antibody reaction, and
( 2 ) 第 1工程で得られる反応生成物を検出する第 2工程  (2) Second step for detecting the reaction product obtained in the first step
の工程を含むことを特徴とする、 試料中のビブリオ属細菌の検出法。 A method for detecting a bacterium of the genus Vibrio in a sample, comprising the step of:
2 . 第 1工程に先立ち、 試料を、 ビブリオ属細菌用選択培地で培養することを 特徴とする、 上記 1に記載のビブリオ属細菌の検出法。 2. The method for detecting a Vibrio bacterium according to 1 above, wherein the sample is cultured in a selective medium for Vibrio bacterium prior to the first step.
3 . 抗体が、 ビブリオ属細菌由来の LDHを抗原として動物に免疫して得られる 抗体である、 上記 1または 2に記載の検出法。  3. The detection method according to the above 1 or 2, wherein the antibody is an antibody obtained by immunizing an animal with LDH derived from a genus Vibrio as an antigen.
4. ビブリオ属細菌が、 腸炎ビブリオ (Vibrio parahaemolyt icus) またはビ ブリオ ·ァルギノリティカス (Vibrio alginolyt icus) である、 上記 1から 3 のいずれかに記載の検出法。  4. The detection method according to any one of the above 1 to 3, wherein the Vibrio bacterium is Vibrio parahaemolyt icus or Vibrio alginolyticas.
5 . ビブリオ属細菌由来の LDHと反応し得る抗体を含むことを特徴とする、 ビ ブリオ属細菌の検出用試薬。 6 . ビブリオ属細菌が、 腸炎ビブリオ (Vibrio paraiiaemolyt icus) またはビ ブリオ ·アルギノリティカス (Vibrio alginolyticus) である、 上記 5に記載 の検出用試薬。 5. A reagent for detecting a Vibrio bacterium, which comprises an antibody capable of reacting with LDH derived from a Vibrio bacterium. 6. The detection reagent according to the above item 5, wherein the bacterium of the genus Vibrio is Vibrio parahaemolyticus or Vibrio alginolyticus.
7 . ビブリォ属細菌由来のレシチン依存性.へモリシンと反応し得る抗体。 発明を実施するための最良の形態  7. Lecithin dependence derived from bacteria of the genus Vibrio. An antibody that can react with hemolysin. BEST MODE FOR CARRYING OUT THE INVENTION
以下、 本発明について詳細に説明する。  Hereinafter, the present invention will be described in detail.
1 . ビブリオ属細菌の検出法  1. Detection of Vibrio spp.
本発明のビブリォ属細菌の検出法は、 以下に説明する第 1および第 2工程を 含むことを特徴とする。  The method for detecting a bacterium of the genus Vibrio of the present invention is characterized by including the following first and second steps.
第 1工程では、 ビブリオ属細菌由来の LDHと反応し得る抗体 (以下 「抗 LDH 抗体」 という) を、 試料と接触させて抗原抗体反応を生じさせる。 試料中に L皿を生産するビブリオ属細菌が存在している場合、 抗 LDH抗体と、 細菌が生 産する LDHとが抗原抗体反応を起こす。  In the first step, an antibody capable of reacting with LDH derived from bacteria of the genus Vibrio (hereinafter referred to as “anti-LDH antibody”) is brought into contact with a sample to generate an antigen-antibody reaction. If the sample contains Vibrio spp. That produces L dishes, the anti-LDH antibody and the LDH produced by the bacterium cause an antigen-antibody reaction.
第 2工程では、 第 1工程で得られる反応生成物を検出する。 以上により試料 中のビブリオ属細菌 (特に腸炎ビブリオまたは Vibrio alginolyticus) の検出 が可能となる。  In the second step, the reaction product obtained in the first step is detected. As described above, detection of Vibrio spp. Bacteria (particularly Vibrio parahaemolyticus or Vibrio alginolyticus) in the sample becomes possible.
本発明において、 抗原抗体反応 (第 1工程)および反応生成物の検出(第 2ェ 程)の方法は、 特に限定されず、 免疫反応を利用する公知の方法が利用可能で ある。 本発明で利用可能な方法としては、 例えば酵素免疫測定法 (EIA) 、 ラ ジォ免疫測定法 (RIA) 、 蛍光免疫測定法 (FIA) 、 電気化学免疫測定法、 免疫 凝集法、 免疫クロマト法などが挙げられる。  In the present invention, the method of the antigen-antibody reaction (first step) and the detection of the reaction product (second step) are not particularly limited, and a known method utilizing an immune reaction can be used. Examples of the method usable in the present invention include enzyme immunoassay (EIA), radioimmunoassay (RIA), fluorescence immunoassay (FIA), electrochemical immunoassay, immunoagglutination, immunochromatography. And the like.
本発明では、 第 1工程に先立ち、 試料を培地で培養し、 ビブリオ属細菌の菌 数を増加させることが好ましい。 これにより、 ビブリオ属細菌の検出感度の向 上が可能となる。 培地は、 ビブリオ属細菌が増殖可能なものであればとくに限 定されないが、 ビブリオ属細菌用選択培地を使用することが特に好ましい。 選 択培地を用いることにより、 試料中のビブリオ属細菌を濃縮することができる 実施例に示す通り、 本発明の検出方法を用いると、 試料中に存在する腸炎ビ ブリオ (Vibrio parahaemolyt icus) またはビブリオ ·アルギノリティカス (Vibrio alginolyt icus) を、 迅速、 簡便かつ正確に検出することができる。 また、 本発明の検出方法は、 抗 LDH抗体と反応し得る他のビブリオ属細菌の検 出法としても使用可能である。 In the present invention, prior to the first step, the sample is preferably cultured in a medium to increase the number of bacteria of the genus Vibrio. This makes it possible to improve the detection sensitivity of Vibrio spp. Bacteria. The medium is not particularly limited as long as it is capable of growing Vibrio spp., But it is particularly preferable to use a selective medium for Vibrio spp. By using a selective medium, it is possible to enrich Vibrio spp. In a sample. As shown in the Examples, when the detection method of the present invention is used, enteritis virus present in a sample can be obtained. Brio (Vibrio parahaemolyt icus) or Vibrio alginolyticas (Vibrio alginolyt icus) can be detected quickly, conveniently and accurately. Further, the detection method of the present invention can also be used as a method for detecting other Vibrio bacteria that can react with an anti-LDH antibody.
本発明において、 試料は特に限定されないが、 例えば、 生及び加工した魚介 類、 飲食品、 海水、 河川水、 食器 ·調理器具等への付着物である。 試料が液状 の場合は、 メンブランフィルターなどで試料を濾過し、 フィルタ一上に微生物 を捕捉したものを試料としても良い。 また、 食品や調理器具などに付着したビ ブリオ属細菌を検出する場合は、 食品や調理器具などを、 食塩水や緩衝液など をしみ込ませた綿棒でふき取り、 得られた付着物を適当な緩衝液や培地に懸濁 したものを試料としてもよい。 さらに、 ストマッカ一等を用いて食品から微生 物を抽出し、 得られた抽出物を試料としてもよい。  In the present invention, the sample is not particularly limited, but includes, for example, raw and processed fish and shellfish, food and drink, seawater, river water, dishes and cooking utensils, and the like. When the sample is in a liquid state, the sample may be filtered using a membrane filter or the like, and a sample obtained by capturing microorganisms on the filter may be used as the sample. When detecting Vibrio spp. Attached to food or cooking utensils, wipe the food or cooking utensils with a cotton swab impregnated with saline solution or buffer solution, and remove the resulting adhering substances appropriately. A sample suspended in a liquid or medium may be used as the sample. Furthermore, microbes may be extracted from food using a stomacher or the like, and the resulting extract may be used as a sample.
「抗 LDH抗体」 は、 ビブリオ属細菌由来の LDHと反応し得る限り、 どのよう なものであってもよく、 例えば、 ビブリオ属細菌由来の LDHを抗原として動物 に免疫して得られる抗体が使用できる。 また、 抗 LDH抗体としては、 ポリク 口一ナル抗体およびモノクローナル抗体のいずれも使用可能である。 さらに、 抗 LDH抗体の遺伝子を用いて調製した組換え抗 LDH抗体も使用可能である。 ポリクローナル抗体は感作された動物の血清から得ることができる。 感作は 抗原である LDH蛋白質を、 哺乳類動物、 好ましくはゥサギ、 山羊及び牛に注射 することにより行うことができる。 通常、 最初の注射に続き、 追加抗原注射を 行い、 免疫応答を最大にした後、 感作された動物の血清を採取する。 モノク ローナル抗体は、 細胞融合によって抗 LDH抗体の産生能を有するハイプリドー マを作出することにより得られる。  The “anti-LDH antibody” may be any antibody as long as it can react with LDH derived from Vibrio sp., For example, an antibody obtained by immunizing an animal with LDH derived from Vibrio sp. As an antigen is used. it can. As the anti-LDH antibody, any of a polyclonal antibody and a monoclonal antibody can be used. Furthermore, a recombinant anti-LDH antibody prepared using the anti-LDH antibody gene can also be used. Polyclonal antibodies can be obtained from the sera of sensitized animals. The sensitization can be carried out by injecting the LDH protein as an antigen into mammals, preferably, egrets, goats and cattle. Normally, the first injection is followed by a booster injection to maximize the immune response, and then sera from the sensitized animals are collected. Monoclonal antibodies can be obtained by producing hybridomas capable of producing anti-LDH antibodies by cell fusion.
LDH蛋白質は腸炎ビブリオの培養物から精製できる。 また、 腸炎ビブリオの LDH遺伝子はすでに公知のものである (Taniguclii et al. , Mi c rob. Pathog. , 1, 425, (1986) ) 。 該遺伝子を、 適当な宿主細胞一ベクター系にて生産させる ことにより、 LDH蛋白質が生産され、 これを精製することにより LDH蛋白質が 単離できる。 LDH蛋白質を抗原として適当な動物を感作することにより、 抗 LDH抗体が得られる。 抗 LDH抗体の遺伝子を用いて大腸菌などの微生物を宿主 として組換え抗体 (s ingle chain Fvや Fab) を作製することができる。 LDH protein can be purified from cultures of Vibrio parahaemolyticus. The LDH gene of Vibrio parahaemolyticus is already known (Taniguclii et al., Microb. Pathog., 1, 425, (1986)). The LDH protein is produced by producing the gene in an appropriate host cell-vector system, and the LDH protein can be isolated by purifying the LDH protein. By sensitizing appropriate animals using LDH protein as an antigen, LDH antibodies are obtained. Using the gene of the anti-LDH antibody, a recombinant antibody (single chain Fv or Fab) can be produced using a microorganism such as Escherichia coli as a host.
抗原抗体反応 (第 1工程)および反応生成物の検出 (第 2工程)の方法に応じて、 抗 LDH抗体は、 化学修飾されていてもよい。 第 1および第 2工程において、 ビ ォチンとストレプトアビジンの反応を利用する方法を採用する場合、 抗 LDH抗 体は、 公知の方法でピオチン化される。  The anti-LDH antibody may be chemically modified depending on the method of the antigen-antibody reaction (first step) and the detection of the reaction product (second step). When a method utilizing the reaction between biotin and streptavidin is employed in the first and second steps, the anti-LDH antibody is biotinylated by a known method.
以下に、 本発明のビブリオ属細菌の検出法の具体例として、 試料を培地で培 養した後に、 抗 LDH抗体を試料と接触させて抗原抗体反応を生じさせ、 次いで 反応生成物を検出する方法を説明する。  Hereinafter, as a specific example of the method for detecting a bacterium of the genus Vibrio of the present invention, a method of culturing a sample in a medium, contacting an anti-LDH antibody with the sample to generate an antigen-antibody reaction, and then detecting a reaction product Will be described.
まず、 試料を調製し、 これを固体培地または液体培地に接種した後、 適当な 条件で培養する。 魚介類や飲食品はそのまま試料とし、 直接培地に接種できる。 飲食品等から微生物を抽出して得られた抽出物を試料としてもよい。 また、 食 品や調理器具に付着した微生物を綿棒でふき取り、 次いで該微生物を培地に移 して培養してもよい。 メンブランフィルタ一などで液体試料を濾過し、 フィル 夕一上に微生物を捕捉した場合は、 該フィルターを固体培地上に設置するか、 捕捉物を液体培地に懸濁することができる。  First, prepare a sample, inoculate it on a solid medium or liquid medium, and culture it under appropriate conditions. Fish, seafood and food and drink can be directly used as samples and inoculated directly into the culture medium. An extract obtained by extracting microorganisms from food or drink or the like may be used as a sample. Alternatively, microorganisms adhering to food or cooking utensils may be wiped off with a cotton swab, and then the microorganisms may be transferred to a culture medium and cultured. When a liquid sample is filtered with a membrane filter or the like and microorganisms are captured on the filter, the filter can be placed on a solid medium or the captured substance can be suspended in the liquid medium.
培地としてはビブリォ属細菌が増殖できるものであればとくに限定されない が、 ビブリオ属細菌用選択培地を使用することにより、 試料中のビブリオ属細 菌を濃縮することができる。 選択培地としては、 TCBS寒天培地、 ビブリオ寒天 培地、 食塩ポリミキシンブイヨン、 アルカリ性ペプトン水 (以上日水社製な ど) 、 1. 5%食塩添加ハート ·インフユ一ジョン ·ブロス (Heart Infusion Broth, 以下 HIBと略す、 Di ico社製) 等が使用できる。 選択培地を用いる場合、 試料を直接、 寒天培地に塗布しても良いし、 また、 試料を液体培地で培養して も良い。 また、 液体培養の後に寒天培地に塗布しても良い。 なお、 ί夜体培地を 用いる場合は、 最確法で定量試験を行うこともできる。  The medium is not particularly limited as long as it can grow Vibrio spp., But by using a selective medium for Vibrio spp., The Vibrio spp. In the sample can be concentrated. Selection media include TCBS agar medium, Vibrio agar medium, salt polymyxin broth, alkaline peptone water (Nissui, etc.), 1.5% salt-added Heart Infusion Broth (HIB) Abbreviation, manufactured by Diico). When a selective medium is used, the sample may be applied directly to the agar medium, or the sample may be cultured in a liquid medium. Further, after liquid culture, it may be applied to an agar medium. When overnight culture medium is used, the quantitative test can be performed by the most probable method.
ビブリォ属細菌の培養温度は 15°C〜45°C、 好ましくは 30°C〜40°C程度であ る。 培養時は通気しても密閉してもよく、 また、 液体培地を使用する場合は、 必要により振とうしてもよい。 培養後に、 抗 LDH抗体を培養物と接触させて抗原抗体反応を生じさせ (第 1 工程) 、 次いで反応生成物を検出する (第 2工程) 。 これらの工程により試料 中の LDHが検出され、 結果として、 LDHを生産するビブリオ属細菌が検出され る。 The cultivation temperature of the genus Vibrio is 15 ° C to 45 ° C, preferably about 30 ° C to 40 ° C. During the culture, the culture may be aerated or closed. If a liquid medium is used, the culture may be shaken as necessary. After the culture, an anti-LDH antibody is brought into contact with the culture to generate an antigen-antibody reaction (first step), and then the reaction product is detected (second step). Through these steps, LDH in the sample is detected, and as a result, Vibrio spp. That produces LDH is detected.
LDHは、 培養物全体、 培養上清、 菌体、 菌体の破砕物のいずれから検出して も良い。 菌体の破砕方法は LDHの抗体認識構造を変化させない方法であればい かなる方法でも良く、 例えば、 超音波処理、 溶菌酵素または溶菌剤による処理、 フレンチプレス等の方法が使用できる。 また、 培養物を一旦、 TCBS寒天培地な どの腸炎ビブリオの選択培地上で培養し、 腸炎ビブリオであると疑われる集落 から、 直接または培地で培養後に LDHを検出してもよい。  LDH may be detected from any of the whole culture, the culture supernatant, the cells, and the disrupted cells. The method of disrupting the cells may be any method as long as it does not change the antibody recognition structure of LDH, and examples thereof include ultrasonic treatment, treatment with a lytic enzyme or a lytic agent, and French press. Alternatively, the culture may be once cultured on a selective medium of Vibrio parahaemolyticus such as TCBS agar medium, and LDH may be detected directly from the colony suspected of Vibrio parahaemolyticus or after culture in the medium.
抗原抗体反応と反応生成物の検出は、 酵素免疫測定法 (EIA) 、 ラジオ免疫 測定法 (RIA) 、 電気化学免疫測定法、 免疫凝集法、 免疫クロマト法等を用い て実施可能である。  The antigen-antibody reaction and the detection of the reaction product can be performed using enzyme immunoassay (EIA), radioimmunoassay (RIA), electrochemical immunoassay, immunoagglutination, immunochromatography, and the like.
例えば、 酵素免疫測定法を採用する場合は、 サンドイッチ法と競合法がある。 サンドイッチ法の場合は、 担体にまず抗 LDH抗体を結合させ、 そののちサンプ ルと接触させ、 次いで標識抗 LDH抗体 (例えば、 抗体一酵素の複合体、 ビォチ ン化抗体) と接触させる。 また、 必要があれば最後に第 2の標識物 (例えば、 ピオチン化ルシフェラーゼーストレブトアビジン複合体) と接触させる。 標識 物または第 2標識物を、 酵素反応により測定することにより LDHが検出できる。 競合法の場合は担体に先ず抗 LDH抗体を結合させ、 そののちサンプルと標識 LDH (例えば、 LDH—酵素の複合体、 ピオチン化 LDH) を添加し、 必要があれば 第 2の標識物 (例えば、 ピオチン化ルシフェラ一ゼーストレブトアビジン複合 体) と接触させ、 標識物または第 2標識物を酵素反応により測定することによ り、 LDHが検出できる。  For example, when using an enzyme immunoassay, there are a sandwich method and a competitive method. In the case of the sandwich method, first, an anti-LDH antibody is bound to a carrier, then brought into contact with a sample, and then contacted with a labeled anti-LDH antibody (for example, an antibody-enzyme complex, biotinylated antibody). Finally, if necessary, a second label (for example, a biotinylated luciferase ostreptoavidin complex) is contacted. LDH can be detected by measuring the label or the second label by an enzyme reaction. In the case of the competitive method, an anti-LDH antibody is first bound to a carrier, and then a sample and a labeled LDH (eg, an LDH-enzyme complex, a biotinylated LDH) are added, and if necessary, a second labeled substance (eg, LDH can be detected by contacting the product with a biotinylated luciferase-sestrebutavidin complex) and measuring the label or the second label by an enzyme reaction.
また、 免疫凝集法を採用する場合は、 まず、 ラテックス粒子や金コロイドな どに抗 LDH抗体を感作させ、 次いで試料と接触させる。 その後に、 反応生成物 である凝集を検出することにより、 LDH力検出できる。  When using the immunoagglutination method, first, an anti-LDH antibody is sensitized to latex particles, gold colloid, or the like, and then the sample is brought into contact with the sample. Thereafter, LDH force can be detected by detecting agglutination, which is a reaction product.
以上の方法により、 試料中のビブリオ属細菌、 特に腸炎ビブリオまたはビブ リオ ·ァルギノリティカス (V. alginolyt icus) が検出可能であるが、 必要に 応じて、 更に公知の方法により確認試験を行う。 By the above method, Vibrio spp., Especially Vibrio parahaemolyticus or Bib Although it is possible to detect Rio alginolyticus (V. alginolyticus), a confirmation test is performed by a known method, if necessary.
なお、 試料中に腸炎ビブリオおよびビブリオ ·アルギノリティカス  Vibrio parahaemolyticus and Vibrio alginolyticus were contained in the sample.
(V. alginolyt icus) が共に存在する場合、 本発明の検出方法では、 両者が同 時に検出される。 腸炎ビブリオとビブリオ ·アルギノリティカス  When both (V. alginolyt icus) are present, both are detected simultaneously by the detection method of the present invention. Vibrio parahaemolyticus and Vibrio alginolyticus
(V. alginolyt icus) のいずれか 1種のみを検出する必要がある場合には、 抗 原抗体反応の実施に先立って、 両者を分別するために選択培地を用いて培養す る。 例えば、 ビブリオ属細菌の選択培地である TCBS寒天培地 (日水) 上では、 白糖非分解性である腸炎ビブリォは緑青色の集落を形成するが、 白糖分解性で あるビブリオ ·アルギノリティカス (V. alginolyt icus) は黄色の集落を形成 することが知られている。 TCBS寒天培地を選択培地とすることにより、 両者の 識別が可能である。  If only one species (V. alginolyt icus) needs to be detected, cultivation is carried out using a selective medium in order to separate the two prior to performing the antigen-specific antibody reaction. For example, on a TCBS agar medium (Nissui), a selective medium for Vibrio spp., Vibrio parahaemolyticus, which is non-degradable by sucrose, forms a green-blue colony, whereas Vibrio arginolyticus (V alginolyt icus) is known to form yellow settlements. By using TCBS agar as the selective medium, both can be distinguished.
2 . ビブリオ属細菌の検出用試薬 2. Detection reagent for Vibrio spp.
本発明の検出用試薬は、 抗 LDH抗体を含むことを特徴とする。 該試薬は、 本発明のビブリオ属細菌の検出法に使用される。 該試薬には、 抗 LDH抗体の 他、 ビブリオ属細菌の検出法に必要な他の成分、 あるいは各反応工程を安定に 進行させるための成分 (防腐剤、 pH調整剤、 酸化防止剤等) が含まれていて もよい。 本発明の検出用試薬の形状は、 溶液状または固体状であってもよい。 溶液状の試薬とは例えば、 抗 LDH抗体を適当な溶媒に溶解した溶液である。 また、 固体状の試薬とは例えば、 免疫測定用のゥエルやラテックス粒子等の固 相担体に、 抗 LDH抗体を固定したものである。 実施例  The detection reagent of the present invention is characterized by containing an anti-LDH antibody. The reagent is used in the method for detecting a bacterium of the genus Vibrio of the present invention. The reagent contains, in addition to the anti-LDH antibody, other components necessary for the detection of Vibrio spp., Or components (preservatives, pH adjusters, antioxidants, etc.) that allow each reaction step to proceed stably. May be included. The shape of the detection reagent of the present invention may be a solution or a solid. The reagent in the form of a solution is, for example, a solution in which an anti-LDH antibody is dissolved in an appropriate solvent. The solid-state reagent is, for example, one in which an anti-LDH antibody is immobilized on a solid carrier such as a well or a latex particle for immunoassay. Example
以下、 実施例により本発明を更に具体的に説明する。  Hereinafter, the present invention will be described more specifically with reference to examples.
実施例 1 Example 1
( 1 ) LDHの調製  (1) Preparation of LDH
腸炎ビブリオの LDH遺伝子がクローニングされている大腸菌 C600pHL591株 (Taniguchi et al., Microb. Pat og. , 1, 425 (1986) ) を、 ΗΙΒ 5 mLにて 37°Cで 8時間振とう培養し、 500 mLの HIBに接種後 37°Cにて 16時間振とう培 養した。 7000Xg、 40分間遠心分離を行い、 菌体を回収した。 この菌体から ニュー (Neu) とネッペル (Neppel) の方法 (J. Biol. Chem. , 240, 3685 (1965) ) に従い浸透圧ショック法によりペリブラズム分画を得た。 E. coli C600pHL591 strain in which the LDH gene of Vibrio parahaemolyticus has been cloned (Taniguchi et al., Microb. Pat og., 1, 425 (1986)) was used in に て 5 mL. The cells were cultured at 37 ° C for 8 hours with shaking, inoculated into 500 mL of HIB, and then cultured at 37 ° C for 16 hours with shaking. The cells were centrifuged at 7000Xg for 40 minutes to collect the cells. Periplasmic fractions were obtained from these cells by the osmotic shock method according to the method of Neu and Neppel (J. Biol. Chem., 240, 3685 (1965)).
これに 65%飽和 (420 g/L) となるように硫酸アンモニゥムを加え、 4°Cで一 晚放置後、 7000Xg、 40分間遠心分離して沈殿を回収した。 得られた沈殿を 0.15 M NaCl/20 mM ヒスチジン一塩酸 (Histidine_HCl) 緩衝液 (pH 5.5) 3 mLに溶かし、 同緩衝液で一晩透析した後、 遠心分離により不溶物を取り除いた。 上清を 0.15 M NaCl/20 mM ヒスチジン—塩酸 (Histidine- HC1) 緩衝液 (pH 5.5) で平衡化した陰イオン交換体 Mono Q HR 5/5カラムに添加し、 高速液体 クロマトグラフィーを行った。 すなわち、 同緩衝液で未吸着蛋白質を洗浄後、 0.9 M NaClを含む同緩衝液で溶出し、 ゥマ赤血球溶血活性 (すなわち LDH活 性) のある画分を回収した。 ゥマ赤血球溶血活性は、 サンプルを 50 ig/mLの レシチン存在下で 0.5%ゥマ赤血球と 37°Cで 2時間反応させて溶血の有無を確 認した。 対照としてレシチン非存在下での反応を行い、 その差を判定した。  To this, ammonium sulfate was added so as to obtain a 65% saturation (420 g / L), left at 4 ° C for a while, and then centrifuged at 7000Xg for 40 minutes to collect a precipitate. The resulting precipitate was dissolved in 3 mL of 0.15 M NaCl / 20 mM histidine monohydrochloride (Histidine_HCl) buffer (pH 5.5), dialyzed against the same buffer overnight, and centrifuged to remove insolubles. The supernatant was added to an anion exchanger Mono Q HR 5/5 column equilibrated with a 0.15 M NaCl / 20 mM histidine-HCl (Histidine-HC1) buffer solution (pH 5.5), and high-performance liquid chromatography was performed. That is, after the unadsorbed protein was washed with the same buffer, the protein was eluted with the same buffer containing 0.9 M NaCl, and a fraction having poma erythrocyte hemolytic activity (ie, LDH activity) was collected. The erythrocyte hemolytic activity was determined by reacting the sample with 0.5% erythrocytes in the presence of 50 ig / mL lecithin at 37 ° C for 2 hours to determine the presence or absence of hemolysis. As a control, a reaction was performed in the absence of lecithin, and the difference was determined.
(2) 抗 LDH抗体の作製、 精製およびピオチン化  (2) Preparation, purification and biotinylation of anti-LDH antibody
(1) で得られた LDHを、 完全フロインドアジュバンド  Completely Freund's adjuvant with LDH obtained in (1)
(Freund's complete adjuvant) と混合してゥサギに免疫し、 抗 LDH抗血清を 調製した。 ついで、 MabTrap GIIキッ卜 (Amersham Pharmacia Biotech社製) を用いて抗 LDH抗血清から抗 LDH抗体の精製を行い、 PD- 10カラム (Amersham Pharmacia Biotech社製)を用いて脱塩を行った。 蛋白濃度は BCAプロテイン アツセィ試薬 (Pierce社製) により測定した。 1.5 mLの抗血清から、 3.5 mL(l.1 mg/mL)の抗 LDH抗体 (ポリクロナール抗体) を精製した。  (Freund's complete adjuvant) to immunize the egret to prepare an anti-LDH antiserum. Subsequently, the anti-LDH antibody was purified from the anti-LDH antiserum using a MabTrap GII kit (Amersham Pharmacia Biotech) and desalted using a PD-10 column (Amersham Pharmacia Biotech). The protein concentration was measured with BCA Protein Atssay reagent (Pierce). From 1.5 mL of antiserum, 3.5 mL (1.1 mg / mL) of anti-LDH antibody (polyclonal antibody) was purified.
精製抗体 1 mL に、 モル比で 10倍のピオチン化試薬 (Sulfo- NHS-LC- Biotin, Pierce社製)を添加し、 氷中にて 2 時間放置してピオチン化を行った。 その後、 PD - 10カラムにて未反応のピオチン化試薬を取り除いた。 上記により得られた ピオチン化抗 LDH抗体を、 本発明の検出用試薬の 1つとした。  To 1 mL of the purified antibody, a 10-fold molar ratio of a biotinylation reagent (Sulfo-NHS-LC-Biotin, manufactured by Pierce) was added, and the mixture was left on ice for 2 hours for biotinylation. Thereafter, unreacted biotinylation reagent was removed with a PD-10 column. The biotinylated anti-LDH antibody obtained above was used as one of the detection reagents of the present invention.
(3) 細菌を含む試料の調製 腸炎ビブリオ 8株、 腸炎ビブリオ以外のビブリオ属の細菌 22株 (表 1、 表 2 ) を、 1. 5%食塩を添加した HIB寒天に塗布し、 37 にて 18時間培養した。 単一集落を 1. 5%食塩を含む HIB液体培地 2 mLにて 5時間振とう培養し、 培養 物 1 mLをマイクロチューブに移し、 遠心分離により培養上清を得た。 該培養 上清を試料とした。 (3) Preparation of sample containing bacteria Eight strains of Vibrio parahaemolyticus and 22 strains of Vibrio spp. Other than Vibrio parahaemolyticus (Tables 1 and 2) were spread on HIB agar supplemented with 1.5% sodium chloride and cultured at 37 for 18 hours. The single colony was cultured with shaking in 2 mL of HIB liquid medium containing 1.5% sodium chloride for 5 hours, 1 mL of the culture was transferred to a microtube, and a culture supernatant was obtained by centrifugation. The culture supernatant was used as a sample.
ビブリオ属以外の細菌 21株 (表 3 ) は HIB寒天培地に塗布し、 37 にて 18 時間培養した。 単一集落を HIB液体培地 2 mLにて 5時間振とう培養し、 培養 物 1 mLをマイクロチューブに移し、 遠心分離により培養上清を得た。 該培養 上清を試料とした。  Twenty-one strains of bacteria other than the genus Vibrio (Table 3) were spread on HIB agar medium and cultured at 37 for 18 hours. The single colony was cultured with shaking in 2 mL of HIB liquid medium for 5 hours, 1 mL of the culture was transferred to a microtube, and a culture supernatant was obtained by centrifugation. The culture supernatant was used as a sample.
( 4 ) 酵素免疫測定法によるビブリオ属細菌の検査  (4) Testing for Vibrio bacteria by enzyme-linked immunosorbent assay
抗 LDH抗体を 10 x g/mLの濃度で含む 60 πιΜ炭酸ナトリウム緩衝液 (ρΗ 9. 6) を調製し、 ずつを、 C 8 'マキシ 'ブレイクアパート ·ヌンク一 イミュノ 'モジュール (C8 MAXI BREAKAPART NUNC-IMMUNO MODULE, Nunc社 製) のゥエルに添加し、 4°Cにて 18時間放置し、 抗 L皿抗体のゥエルへの吸着 を行った。 抗体が吸着したゥエルを、 本発明のビブリオ属細菌の検出用試薬の 1つとした。  Prepare a 60 πιΜ sodium carbonate buffer (ρΗ 9.6) containing anti-LDH antibody at a concentration of 10 xg / mL, and add each to a C8 MAXI BREAKAPART NUNCHI IMUNO module C8 MAXI BREAKAPART NUNC- IMMUNO MODULE, manufactured by Nunc) and left at 4 ° C for 18 hours to allow the anti-L dish antibody to adsorb to the well. The well to which the antibody was adsorbed was used as one of the reagents for detecting Vibrio bacteria of the present invention.
0. 1%の Tween 20を含む卜リス緩衝食塩水 (Tris Buf fered Sal ine (以下 「TBS」と略す) ) で 3回洗浄後、 300 Lの 25% プロックエース(大日本製薬社 製)を添加し、 37°Cにて 1時間放置し、 ゥエルのブロッキングを行った。 0. 1% の Tween 20を含む TBSで 3回洗浄後、 ( 3 ) で調整した試料 または対 照として HIB IOO Lを添加し、 37 で 1時間放置し、 固相抗体と試料中の LDH の反応を行った。  After washing three times with Tris buffered saline (hereinafter abbreviated as “TBS”) containing 0.1% Tween 20, 300 L of 25% PROC Ace (Dainippon Pharmaceutical Co., Ltd.) was added. The mixture was added and left at 37 ° C. for 1 hour to perform blocking of the wells. After washing three times with TBS containing 0.1% Tween 20, add the sample prepared in (3) or add HIB IOOL as a control, leave it at 37 for 1 hour, and remove the solid phase antibody and LDH in the sample. The reaction was performed.
0. 1%の Tween 20を含む TBSで 3回洗浄後、 10%ブロックエースで 3, 000倍に 希釈したピオチン化抗 LDH抗体 ( (2 ) で調製したもの) を IOO L添加し、 37°Cで 1時間放置し、 固相抗体に結合した LDHとピオチン化抗 LDH抗体の反応 を行った。 0. 1%の Tween 20を含む TBSで 3回洗浄後、 生物発光測定用試薬 キット (商品名: Intel i teAB、 キッコ一マン社製) のピオチン化ルシフェラー ゼーストレブトアビジン複合体溶液 (複合体) IOO Lを添加し、 37°Cにて 30 分放置し、 ピオチン化抗 LDH抗体と複合体との反応を行った。 0. 1 の Tween 20 を含む TBSで 3回洗浄後、 C 8 ·マキシ ·ブレイクァパート 'ヌンクーイミュ ノ ·モジュール (C8 MAXI BREAKAPART NUNC- 1画 NO MODULE, Nunc社製) のゥ エルを切り離し、 発光測光用チューブ (ルミチューブ, キッコ一マン社製) に 装着した。 インテライト A B (Intel iteAB) の発光基質溶液 を添加し, 発光検出器ルミテスタ一 K210 (キッコーマン社製) で発光量を測定した。 対照 である HIBの 2倍以上の発光値を示した試料を陽性、 2倍未満の発光量を示し た試料を陰性と判定した。 After washing three times with TBS containing 0.1% Tween 20, add 10 mL of biotinylated anti-LDH antibody (prepared with (2)) diluted 3,000-fold with 10% Block Ace and add 37 ° C. C for 1 hour, and the reaction between LDH bound to the solid phase antibody and the biotinylated anti-LDH antibody was performed. After washing three times with TBS containing 0.1% Tween 20, the biotinylated reagent kit (trade name: InteliteAB, manufactured by Kikkoman Co., Ltd.) containing a biotinylated luciferase zestrebutavidin complex solution (complex ) Add IOO L and set at 37 ° C 30 Then, the mixture was allowed to react with the biotinylated anti-LDH antibody and the complex. After washing 3 times with TBS containing Tween 20 of 0.1, cut off the cell of C8 MAXI BREAKAPART NUNC-1 (C8 MAXI BREAKAPART NUNC-1 picture NO MODULE, Nunc) and emit light. Attached to a photometric tube (Lumitube, manufactured by Kikkoman Co., Ltd.). The luminescence substrate solution of Intellite AB was added, and the luminescence was measured with a luminescence detector Lumitester-K210 (manufactured by Kikkoman). Samples showing a luminescence value more than twice that of the control HIB were judged as positive, and samples showing less than twice the amount of luminescence were judged as negative.
その結果、 すべての腸炎ビブリオおよびビブリオ ·アルギノリティカス (V. alginolyt icus) が陽性となり、 一方、 これら 2種以外のビブリオ属の細 菌および非ビブリオ属の細菌はすべて陰性となった (表 1〜3 ) 。 すなわち、 抗 LDH抗体を用いた酵素免疫測定法により、 用いた細菌の中から、 腸炎ビブリ ォとビブリオ ·アルギノリティカス (V. alginolyt icus) の 2種のみが特異的 に検出できることが示された。  As a result, all Vibrio parahaemolyticus and V. alginolyticus (V. alginolyticus) were positive, while all other Vibrio and non-Vibrio bacteria were negative (Table 1). ~ 3). In other words, the enzyme immunoassay using anti-LDH antibody showed that only two species, Vibrio parahaemolyticus and V. alginolyticus, could be specifically detected from the bacteria used. .
実施例 2 ラテックス凝集法によるビブリオ属細菌の検出 Example 2 Detection of Vibrio spp. By latex agglutination method
ラテックス凝集法によるビブリオ属細菌の検出は、 以下の方法により実施可 能である。  Detection of Vibrio spp. Bacteria by the latex agglutination method can be performed by the following method.
まず、 ラテックス粒子への抗体の感作を行う。 ラテックス粒子としてポリ ビーズ'ポリスチレン ·マイクロスフェア一ズ (Polybead polystyrene microspheres, 直径 Ι ΠΙ, Polysciences, Inc.製) を用いる。 ラテックス粒 子 2. 5%懸濁液 0. 5 mLをマイク口チューブに入れ、 1 mLのホウ酸緩衝液 (0. 1 M Borate, pH 8. 5) を加え、 混濁後、 遠心分離によりラテックス粒子を回収す る。 これをホウ酸緩衝液 1 mLに再懸濁して遠心分離する操作を 2回繰り返し たのち、 1 mLのホウ酸緩衝液に懸濁する。 実施例 1 ( 2 ) で得られた抗 LDH抗 体を 25 g/mLとなるように加え、 室温にて 16時間、 20 rpmの振とう下で放 置する。  First, the antibody is sensitized to the latex particles. Polybead polystyrene microspheres (diameter Ι Ι, manufactured by Polysciences, Inc.) are used as latex particles. Latex particles 2.5 Put 0.5 mL of suspension into a microphone mouth tube, add 1 mL of borate buffer (0.1 M Borate, pH 8.5), and after turbidity, centrifuge for latex Collect the particles. The procedure of resuspending this in 1 mL of borate buffer and centrifuging is repeated twice, and then resuspended in 1 mL of borate buffer. The anti-LDH antibody obtained in Example 1 (2) is added to a concentration of 25 g / mL, and left at room temperature for 16 hours under shaking at 20 rpm.
遠心分離によりラテックス粒子を回収した後、 lmLの 1 %牛血清アルブミン 入りのホウ酸緩衝液に懸濁し、 室温にて 20 rpmの振とう下で 30分間放置する。 この操作を更に 2回繰り返した後、 遠心分離によりラテックス粒子を回収し、 1 mLの貯蔵緩衝液 (20 mMリン酸ナトリウム, 150 mM NaCl, 1% BSA, 5% glycerol, 0. 1% NaN3, H 7. 4) に懸濁する。 上記で得られる、 抗 LDH抗体を 感作させたラテックス粒子は本発明の検出用試薬の 1つである。 After collecting the latex particles by centrifugation, suspend them in 1 mL of borate buffer containing 1% bovine serum albumin and leave at room temperature with shaking at 20 rpm for 30 minutes. After repeating this operation twice more, the latex particles were collected by centrifugation, and 1 mL of a storage buffer (20 mM sodium phosphate, 150 mM NaCl, 1% BSA, 5% glycerol, 0.1% NaN 3 , H7.4). The latex particles sensitized with the anti-LDH antibody obtained above are one of the detection reagents of the present invention.
実施例 1 ( 3 ) で調製した試料および上述の抗 LDH抗体を感作させたラテツ クス粒子を希釈液 (0. 5%牛血清アルブミンと 0. 1% NaN3 を含むリン酸塩緩衝食 塩水) にてそれぞれ 10倍希釈を行う。 希釈した試料のそれぞれ 25 2 Lずつを V型マイクロプレート (コース夕一社製) の各ゥエルに滴下する。 ついで、 希 釈したラテックス粒子 25 ずつをその上に滴下し、 マイクロプレート用ミ キサ一で振とう攪拌した後、 室温にて 18 時間静置し、 各ゥエルの凝集を観察 する。 The sample prepared in Example 1 (3) and the latex particles sensitized with the anti-LDH antibody described above were diluted with a diluent (phosphate buffered saline containing 0.5% bovine serum albumin and 0.1% NaN 3). ) Dilute each 10-fold with. Add 252 L of each diluted sample to each well of a V-shaped microplate (Course Yuichisha). Next, 25 diluted dilute latex particles are added dropwise thereto, and the mixture is shaken and stirred with a mixer for a microplate, and then left at room temperature for 18 hours to observe aggregation of each well.
腸炎ビブリオおよびビブリオ'アルギノリティカス (V. alginolyt icus) の 培養上清はラテックス凝集を起こすが、 その他の培養上清はラテックス凝集を 起こさない。 すなわち、 抗 LDH抗体を感作させたラテック粒子を用いることに より、 腸炎ビブリオおよびビブリオ ·アルギノリティカス (V. alginolyt icus) を効率よく検出することができる。  Culture supernatants of Vibrio parahaemolyticus and Vibrio alginolyticus (V. alginolyticus) cause latex aggregation, but other culture supernatants do not. That is, by using the Latec particles sensitized with the anti-LDH antibody, Vibrio parahaemolyticus and V. alginolyticus can be efficiently detected.
実施例 3 選択培養の後に抗原抗体反応を実施する方法 Example 3 Method of performing antigen-antibody reaction after selective culture
上述の酵素免疫測定法およびラテックス凝集法では、 LDHを生産する腸炎ビ ブリオおよびビブリオ ·アルギノリティカス (V. alginolyt icus) のみを検出 することが可能である。 腸炎ビブリオは食中毒の原因となり食品衛生上管理を 必要とする細菌であるが、 ビブリオ ·アルギノリティカス (V. alginolyt icus) は食中毒の原因とはならないため、 両者を区別することが望ましい。 ビブリオ属細菌の選択培地である TCBS寒天培地 (日水社製) 上では白糖非 分解性である腸炎ビブリォは緑青色の集落を形成するが、 白糖分解性であるビ ブリオ ·アルギノリティカス (V. alginolyt icus) は黄色の集落を形成するこ とが知られている。 このため、 両者の識別が容易である。 そこで、 実施例 1 ( 4 ) で使用したビブリオ属細菌および非ビブリオ属細菌の、 TCBS寒天培地上 での集落の形状を調べた (表 1〜3 ) 。 1. 5%食塩を添加した HIB培地 (ビブリオ属細菌) または HIB培地 (非ビブリ ォ属細菌) 2 mLでそれぞれの株を 37°C、 24時間培養した後、 TCBS寒天培地に 塗布し、 37°Cにて 18時間培養した。 TCBS寒天培地上での成育の有無および集 落の色を観察した。 TCBS寒天培地上では、 用いた 8株すベての腸炎ビブリオが 緑青色の集落を形成し、 用いた 3株すベてのビブリオ'アルギノリティカス (V. alginolyt icus) が黄色の集落を形成した (表 1 ) 。 腸炎ビブリオとビブ リオ ·アルギノリティカス (V. alginolyt icus) 以外のビブリオ属細菌の大部 分は TCBS寒天培地上で成育し、 緑青色または黄色の集落を形成した (表 1、 表 2 ) 。 用いた全ての非ビブリオ属細菌は、 TCBS寒天培地上では成育しないか または成育しても著しく小さい集落しか形成せず、 腸炎ビブリオやビブリオ - アルギノリティカス (V. alginolyt icus) とは容易に識別可能であった (表 3 ) 。 The enzyme immunoassay and the latex agglutination method described above can detect only Vibrio parahaemolyticus and V. alginolyticus producing LDH. Vibrio parahaemolyticus is a bacterium that causes food poisoning and requires food hygiene control, but V. alginolyticus (V. alginolyt icus) does not cause food poisoning, so it is desirable to distinguish between the two. Vibrio parahaemolyticus, which is non-sucrose-degrading on TCBS agar medium (manufactured by Nissui), which is a selective medium for Vibrio bacteria, forms a green-blue colony. alginolyt icus) is known to form yellow settlements. For this reason, it is easy to distinguish between the two. Therefore, the shape of the colonies on the TCBS agar medium of the Vibrio spp. Bacteria and the non-Vibrio spp. Bacteria used in Example 1 (4) was examined (Tables 1-3). 1. After culturing each strain for 24 hours at 37 ° C in 2 mL of HIB medium (Vibrio spp. Bacteria) or HIB medium (Non-vibrio spp. Bacteria) supplemented with 5% sodium chloride, spread on TCBS agar medium, The cells were cultured at ° C for 18 hours. The presence or absence of growth on TCBS agar medium and the color of the colonies were observed. On TCBS agar, all eight strains of Vibrio parahaemolyticus used form green-blue colonies, and all three strains of Vibrio alginolyticus (V. alginolyt icus) used form yellow colonies. (Table 1). Most Vibrio bacteria other than Vibrio parahaemolyticus and V. alginolyticus grew on TCBS agar and formed green-blue or yellow colonies (Tables 1 and 2). All non-Vibrio bacteria used did not grow or formed very small colonies on TCBS agar, and were easily distinguished from Vibrio parahaemolyticus and Vibrio alginolyticus (V. alginolyticus). It was possible (Table 3).
TCBS寒天培地で成育したビブリオ属細菌の単一集落を、 1. 5%食塩を含む HIB 液体培地 mLに懸濁し、 37°Cにて 6時間培養した後、 培養物 lmLをマイク口 チューブに移し、 遠心分離により培養上清を調製した。 この培養上清を実施例 1 ( 4 ) 記載の免疫測定法により検査したところ、 腸炎ビブリオおよびビブリ ォ*アルギノリティカス (V. alginolyt icus) は陽性となり、 これらの株以外 はすべて陰性であった。 また、 上記の腸炎ビブリオおよびビブリオ ·アルギノ リティカス (V. alginolyt icus) の選択培養は、 実施例 2記載のラテックス凝 集法に先立って実施することも可能である。  A single colony of Vibrio spp.grown on TCBS agar was suspended in mL of HIB liquid medium containing 1.5% sodium chloride, incubated at 37 ° C for 6 hours, and then 1 mL of the culture was transferred to a microphone mouth tube. The culture supernatant was prepared by centrifugation. When the culture supernatant was examined by the immunoassay described in Example 1 (4), Vibrio parahaemolyticus and V. alginolyticus (V. alginolyticus) were positive, and all the other strains were negative. . The selective culture of Vibrio parahaemolyticus and Vibrio alginolyticus (V. alginolyticus) can also be performed prior to the latex aggregation method described in Example 2.
TCBS寒天上での選択培養を行なった後に、 抗 LDH抗体を用いた検出法を実施 することにより腸炎ビブリオとビブリオ 'アルギノリティカス  After performing selective culture on TCBS agar, detection using anti-LDH antibody is performed to obtain Vibrio parahaemolyticus and Vibrio alginolyticus.
(V. alginolyt icus) をそれぞれ同定することが可能であることが示された。 菌株名 EIA* TCBS^ 腸炎ビブリオ (V. parahaemolyticus) AQ3354 陽性 緑青色 腸炎ビブリオ (V. parahaemolyticus) RIMD2210518 陽性 緑青色 腸炎ビブリオ (V. parahaemolyticus) 93-200 陽性 緑青色 腸炎ビブリオ (V. parahaemolyticus) 93-347 陽性 緑青色 tlノ リ V. ΓαίΙ θΐηθΐγΐ lCUS V i Q 腸炎ビブリオ (V. parahaemolyticus) OP- 377 陽性 緑青色 腸炎ビブリオ (V. parahaemolyticus) 93-100 陽性 緑青色 腸炎ビブリオ (V. parahaemolyticus) 93-346 陽性 緑青色 ビブリオ ·アルギノリティカス (V. alginolyticus) (V. alginolyt icus) respectively. Strain name EIA * TCBS ^ V. parahaemolyticus AQ3354 positive green-blue V. parahaemolyticus RIMD2210518 positive green-blue V. parahaemolyticus 93-200 positive green-blue V. parahaemolyticus 93- 347 positive green-blue tl paste V. ΓαίΙ θΐηθΐγΐ lCUS V i Q V. parahaemolyticus OP-377 positive green-blue enteritis vibrio (V. parahaemolyticus) 93-100 positive green-blue enteritis vibrio (V. parahaemolyticus) 93- 346 positive green blue Vibrio alginolyticus (V. alginolyticus)
π UτA/ Λ Q 7 ΠΠ 1 陽性 黄色 Ao〖 UU 1 π UτA / Λ Q 7 ΠΠ 1 Positive Yellow Ao 〖UU 1
しノ リ z«i ノレ ノ リアイス Jス v. aiginoiyi icusノ 陽性 黄色 OKA87-003 Positive z «i Nore no Riice Js v. Aiginoiyi icus no Positive Yellow OKA87-003
ビブリオ ·ァルギノリティカス (V. alginolyticus) V. alginolyticus
陽性 黄色 0KA87-004  Positive yellow 0KA87-004
ビブリオ ·ホリザェ (V. hollisae) CDC9041-81 陰性 緑青色 ビブリオ,ホリサェ (V. hollisae) CDC0075-80 陰性 緑青色 ビブリオ ·フル二ッシ (V. furnissii ) Q17 陰性 黄色 ビブリオ ·フル二ッシ (V. furnissii ) 画 4119 陰性 黄色Vibrio hollisae (V. hollisae) CDC9041-81 negative green-blue Vibrio, hollisae (V. hollisae) CDC0075-80 negative green-blue Vibrio furnissii (V. furnissii) Q17 negative yellow picture 4119 negative yellow
*実施例 1 (4) の酵素免疫測定法での結果 * Results from the enzyme immunoassay of Example 1 (4)
«TCBS寒天培地上での集落の色 «Color of colonies on TCBS agar
表 2 Table 2
菌株名 EIAネ TCBS« Strains EIA TCBS «
16 ビブリオ ·メチュニコヴィ (V. metschnikovii) 陰性 黄色 ATCC11171 16 V. metschnikovii Negative Yellow ATCC11171
17 ビブリオ ·フルビアリス (V. fluvialis) AQ0005 陰性 黄色 17 Vibrio fluvialis (V. fluvialis) AQ0005 negative yellow
18 ビブリオ *フルビアリス (V. fluvialis) AQ0012 陰性 黄色 18 Vibrio * Fluvialis (V. fluvialis) AQ0012 negative Yellow
19 ビブリオ ·アングイラルム (V. anguillarum) 陰性 黄色19 Vibrio anguillarum (V. anguillarum) negative yellow
INし ΜΰδώθIN then Μΰδώθ
l "ノ7* 1 )]  l "No 7 * 1)]
20 t リ 1 -^^!r · V J フノレ / (V V. dllgl ΐ 1 Ί丄 1丄 dつ πrUιτlτIU 陰性 成育せ.ず 20 t ri 1-^^! R · V J Funore / (V V.dllgl ΐ 1 Ί 丄 1 丄 d πrUιτlτIU Negative No growth.
NCMB829 NCMB829
ビブリオ ·スプレンディダス (V. splendidus)  Vibrio splendidus (V. splendidus)
21 陰性 黄色 画 4716  21 Negative yellow stroke 4716
22 ビブリオ ·コレラ (V. cholerae) non-01 NCTC4716 陰性 黄色 ώϋ tiノ リ · -iレフ v. ciioieraeノ u丄 ΐώ^ 115¾佥 1土 臾 /1 C ノ リ -J \ V. CflOierdeノ Ul ύΟΛο 1¾ 1土 臾 1±i 22 Vibrio cholera (V. cholerae) non-01 NCTC4716 Negative Yellow ώϋ ti nori -i ref v. Ciioierae no u 丄 ΐώ ^ 115¾ 佥 1 soil 臾 / 1 C glue -J \ V. 1¾ 1 Tsuchi 1 ± i
OP; OP;
ノ リチ^! , 八フ (V τ 1η11ΐ丄τ 11τι1ί上しi 1i1c'ノi Π W9Π U全' 1' aw? F¾ t±i Norichi ^! , 8 hu (V τ 1η11ΐ 丄 τ 11τι1ί rises i 1i1c'no i Π W9Π U all '1' aw? F¾ t ± i
26 ビブリオ ·ミミカス (V. mimicus) 48Pt 陰性 緑青色 26 V. mimicus 48Pt negative Green-blue
27 ビブリオ ·バルニフィカス (V. vulnificus) 陰性 緑青色 strain B 27 Vibrio vulnificus (V. vulnificus) negative green-blue strain B
28 ビブリオ ·パルニフィカス (V. vulnificus) 陰性 緑青色 strain C 28 Vibrio parnificus (V. vulnificus) negative green-blue strain C
29 ビブリオ 'ハーベイ (V· harveyi) OKA82-557 陰性 成育せず 29 Vibrio 'Harveyi' OKA82-557 negative No growth
30 ビブリオ ·ダムセラ (V. damsel a) ATCC33539 陰性 緑青色30 V. damsel a ATCC33539 negative greenish blue
*実施例 1 (4) の酵素免疫測定法での結果 * Results from the enzyme immunoassay of Example 1 (4)
«TCBS寒天培地上での集落の色 表 3 «Color of colonies on TCBS agar Table 3
Figure imgf000018_0001
表 3 (つづき)
Figure imgf000018_0001
Table 3 (continued)
Figure imgf000019_0001
産業上の利用可能性
Figure imgf000019_0001
Industrial applicability
本発明により、 ビブリオ属細菌由来の LDHと反応し得る抗体を用いて試料中 のビブリオ属細菌が生産する LDHを検出することにより、 迅速、 簡便かつ正確 にビブリオ属細菌 (特に、 腸炎ビブリオまたは Vibrio alginolyt icus) が検出 できることが示された。 また、 本発明により、 ビブリオ属細菌由来の LDHと反 応し得る抗体を含むことを特徴とする、 ビブリオ属細菌の検出用試薬が提供さ れた。  According to the present invention, by detecting an LDH produced by a Vibrio bacterium in a sample using an antibody capable of reacting with LDH derived from a Vibrio bacterium, a Vibrio bacterium (particularly, Vibrio parahaemolyticus or Vibrio spp. alginolyt icus) was detected. In addition, the present invention provides a reagent for detecting Vibrio bacteria, which comprises an antibody capable of reacting with LDH derived from Vibrio bacteria.
食品衛生検査指針による従来の方法では、 選択寒天培地上の腸炎ビブリオと 疑わしい集落を同定する場合、 1次確認テスト (6種類) に 1日、 2次確認テ スト (4種類) に 1日、 合計で 2日 (10種類の試験) 必要であった。  According to the conventional method based on the Food Hygiene Inspection Guidelines, when identifying Vibrio parahaemolyticus and suspicious colonies on the selective agar medium, one day for the primary confirmation test (six types) and one day for the secondary confirmation test (four types) A total of 2 days (10 tests) were required.
これに対し、 実施例 1および 3記載の酵素免疫測定法では、 選択寒天培地上 の集落から 1種類の試験でその日のうちに、 腸炎ビブリオおよびビブリオ-ァ ルギノリティカス (V. alginolyt icus) を同定可能である。 また、 実施例 2お よび 3記載のラテックス凝集法では、 選択寒天培地上の集落から 1種類の試験 で翌日に同定可能である。 本発明の方法を用いることで、 従来法より操作が簡 便になり、 検査時間が 1 — 2日間短縮されることが示された。  In contrast, in the enzyme immunoassays described in Examples 1 and 3, Vibrio parahaemolyticus and Vibrio alginolyticus (V. alginolyticus) can be identified within a single test day from a colony on a selective agar medium. It is. Also, in the latex agglutination method described in Examples 2 and 3, it is possible to identify from the colonies on the selective agar medium the next day by one type of test. It has been shown that the use of the method of the present invention makes the operation simpler than the conventional method and shortens the inspection time by one to two days.
本発明は、 食品衛生、 医療、 ビブリオ属細菌の学術研究等の分野において有 用である。  INDUSTRIAL APPLICABILITY The present invention is useful in fields such as food hygiene, medical treatment, and scientific research on bacteria of the genus Vibrio.

Claims

請 求 の 範 囲 The scope of the claims
1 . ( 1 ) ビブリオ属細菌由来のレシチン依存性へモリシンと反応し得る抗体 を、 試料と接触させて抗原抗体反応を生じさせる第 1工程、 及び 1. (1) contacting an antibody capable of reacting with lecithin-dependent hemolysin derived from a bacterium of the genus Vibrio with a sample to generate an antigen-antibody reaction, and
( 2 ) 第 1工程で得られる反応生成物を検出する第 2工程、  (2) a second step of detecting a reaction product obtained in the first step,
を含むことを特徴とする、 試料中のビブリオ属細菌の検出法。 A method for detecting a bacterium of the genus Vibrio in a sample, comprising:
2 . 第 1工程に先立ち、 試料を、 ビブリオ属細菌用選択培地で培養することを 特徴とする、 請求の範囲第 1項記載のビブリォ属細菌の検出法。  2. The method for detecting Vibrio bacteria according to claim 1, wherein the sample is cultured in a selective medium for Vibrio bacteria prior to the first step.
3 . 抗体が、 ビブリオ属細菌由来のレシチン依存性へモリシンを抗原として動 物に免疫して得られる抗体である、 請求の範囲第 1項記載の検出法。  3. The detection method according to claim 1, wherein the antibody is an antibody obtained by immunizing an animal with lecithin-dependent hemolysin derived from a bacterium of the genus Vibrio as an antigen.
4. 抗体が、 ビブリオ属細菌由来のレシチン依存性へモリシンを抗原として動 物に免疫して得られる抗体である、 請求の範囲第 2項記載の検出法。  4. The detection method according to claim 2, wherein the antibody is an antibody obtained by immunizing an animal with lecithin-dependent hemolysin derived from a bacterium of the genus Vibrio as an antigen.
5 . ビブリオ属細菌が、 腸炎ビブリオまたはビブリオ ·アルギノリティカスで ある、 請求の範囲第 1項〜第 4項のいずれかに記載の検出法  5. The detection method according to any one of claims 1 to 4, wherein the Vibrio bacterium is Vibrio parahaemolyticus or Vibrio alginolyticus.
6 . ビブリオ属細菌由来のレシチン依存性へモリシンと反応し得る抗体を含む ことを特徴とする、 ビブリオ属細菌の検出用試薬。  6. A reagent for detecting Vibrio bacteria, which comprises an antibody capable of reacting with lecithin-dependent hemolysin derived from Vibrio bacteria.
7 . ビブリォ属細菌が、 腸炎ビブリォまたはビブリォ ·アルギノリティカスで ある、 請求の範囲第 6項記載の検出用試薬。  7. The detection reagent according to claim 6, wherein the Vibrio bacterium is Vibrio parahaemolyticus or Vibrio arginolitis.
8 . ビブリォ属細菌由来のレシチン依存性へモリシンと反応し得る抗体。  8. An antibody capable of reacting with lecithin-dependent haemolysin from Vibrio spp.
PCT/JP2002/001064 2001-02-09 2002-02-08 Method of detecting bacterium belonging to the genus vibrio, detection reagent and antibody to be used therein WO2002065131A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002564598A JPWO2002065131A1 (en) 2001-02-09 2002-02-08 Methods and reagents for detecting Vibrio bacteria and antibodies used therefor

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001-34012 2001-02-09
JP2001034012 2001-02-09

Publications (1)

Publication Number Publication Date
WO2002065131A1 true WO2002065131A1 (en) 2002-08-22

Family

ID=18897687

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2002/001064 WO2002065131A1 (en) 2001-02-09 2002-02-08 Method of detecting bacterium belonging to the genus vibrio, detection reagent and antibody to be used therein

Country Status (2)

Country Link
JP (1) JPWO2002065131A1 (en)
WO (1) WO2002065131A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006017554A (en) * 2004-06-30 2006-01-19 Daikin Ind Ltd Magnetic bead and microbe detection method
JP2013085503A (en) * 2011-10-17 2013-05-13 Osaka Prefecture Univ Method for detecting vibrio parahaemolyticus
CN106950368A (en) * 2017-03-11 2017-07-14 中国海洋大学 A kind of Test paper of pathogenicity vibrio alginolyticus
CN110734491A (en) * 2019-11-21 2020-01-31 上海交通大学医学院 Kit for detecting vibrio parahaemolyticus and detection method
CN113121682A (en) * 2019-12-30 2021-07-16 中国科学院上海营养与健康研究所 Monoclonal antibody for specifically recognizing vibrio parahaemolyticus O3: K6 and application thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BEJ ET AL.: "Detection of total and hemolysin-producing vibrio parahaemolyticus", JOURNAL OF MICROBIOLOGICAL METHODS, vol. 36, pages 215 - 225, XP002909008 *
MCCARTHY ET AL.: "Evaluation of alkaline phosphatase- and digoxigenin-labelled probes for detection of the thermolabile hemolysis gene of vibrio parahaemolyticus", LETTERS IN APPLIED MICROBIOLOGY, vol. 28, 1999, pages 66 - 70, XP002909007 *
SHINODA ET AL.: "Purification and characterization of a lecithin-dependent haemolysin", JOURNAL OF GENERAL MICROBIOLOGY, vol. 137, 1991, pages 2705 - 2711, XP002909006 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006017554A (en) * 2004-06-30 2006-01-19 Daikin Ind Ltd Magnetic bead and microbe detection method
JP2013085503A (en) * 2011-10-17 2013-05-13 Osaka Prefecture Univ Method for detecting vibrio parahaemolyticus
CN106950368A (en) * 2017-03-11 2017-07-14 中国海洋大学 A kind of Test paper of pathogenicity vibrio alginolyticus
CN106950368B (en) * 2017-03-11 2019-02-15 中国海洋大学 A kind of Test paper of pathogenicity vibrio alginolyticus
CN110734491A (en) * 2019-11-21 2020-01-31 上海交通大学医学院 Kit for detecting vibrio parahaemolyticus and detection method
CN110734491B (en) * 2019-11-21 2022-03-25 上海交通大学医学院 Kit for detecting vibrio parahaemolyticus and detection method
CN113121682A (en) * 2019-12-30 2021-07-16 中国科学院上海营养与健康研究所 Monoclonal antibody for specifically recognizing vibrio parahaemolyticus O3: K6 and application thereof
CN113121682B (en) * 2019-12-30 2022-08-26 中国科学院上海营养与健康研究所 Monoclonal antibody for specifically recognizing vibrio parahaemolyticus O3: K6 and application thereof

Also Published As

Publication number Publication date
JPWO2002065131A1 (en) 2004-09-09

Similar Documents

Publication Publication Date Title
CN101065497B (en) Microbubbles for affinity separation
US4677055A (en) Immunological detection of bacterial pathogens with antibody-containing magnetic gel
Welch et al. Bacteremia due to Rochalimaea henselae in a child: practical identification of isolates in the clinical laboratory
EP0330688B1 (en) Detection methods
Li et al. Specific identification and enumeration of Acetobacter diazotrophicus in sugarcane
JPH05264553A (en) Antigen prepared for detecting helicobacter pyroly
JP5874122B2 (en) Detection method for Vibrio parahaemolyticus
US5415997A (en) Method for detecting low levels of microorganisms
EP0634018A1 (en) Method of detecting microorganisms
Pongsunk et al. Rapid identification of Burkholderia pseudomallei in blood cultures by a monoclonal antibody assay
US6004766A (en) Method for detecting low levels of microorganisms
US4617264A (en) Pretreatment method and composition
JP3773633B2 (en) Analysis method and reagent for E. coli O157
Jadeja et al. Immunomagnetic separation of Vibrio vulnificus with antiflagellar monoclonal antibody
WO2002065131A1 (en) Method of detecting bacterium belonging to the genus vibrio, detection reagent and antibody to be used therein
US10288610B2 (en) Vitro assays for detecting Salmonella enterica serotype typhi
US20030059839A1 (en) Method for detecting pathogens using immunoassays
US4178359A (en) Immunoassay method
JP3614779B2 (en) Antibody for detection of beer harmful lactic acid bacteria and its diagnostic use
US6689572B1 (en) E. coli agglutination assay
KR101094974B1 (en) Novel Biomarkers For the Serodiagnosis of Crohn?s disease
EP0209554A1 (en) Immunoassay systems for the detection of salmonella
CA2078162A1 (en) Specific anti-salmonella monoclonal reagents, and unique serological approach for the detection of different common serotypes of salmonella and the like
KR101105168B1 (en) Novel Biomarkers For the Serodiagnosis of Crohn’s disease
JPH09133684A (en) Method and reagent for detecting specified bacterium in food

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AU BA BB BG BR BZ CA CN CO CR CU CZ DM DZ EC EE GD GE HR HU ID IL IN IS JP KR LC LK LR LT LV MA MG MK MN MX NO NZ OM PH PL RO SG SI SK TN TT UA US UZ VN YU ZA

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2002564598

Country of ref document: JP

122 Ep: pct application non-entry in european phase